Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biomet's preemption bid fails, company proceeds to trial over metal hips
Mass Device
Thursday, August 29, 2013 - 9:33am
tags:
Biomet, preemption, metal hip implants, devices
Zealand Pharma, Eli Lilly sign obesity, diabetes research deal
Reuters
Thursday, August 29, 2013 - 9:31am
tags:
Eli Lilly, Zealand Pharma, obesity, diabetes, R&D
Pfizer completes pneumococcal pneumonia case accrual for CAPiTA
The Fly on the Wall
Thursday, August 29, 2013 - 9:09am
tags:
Pfizer, pneumococcal disease, Prevnar 13, vaccines
FDA grants priority review to blood cancer treatment from Pharmacyclics
Yahoo/AP
Thursday, August 29, 2013 - 9:07am
tags:
FDA, Pharmacyclics, Janssen, JNJ, ibrutinib, mantle cell lymphoma, chronic lymphocytic leukemia
Raptor Pharmaceutical Corporation: A Dose Of Reality For Investors
Seeking Alpha
Thursday, August 29, 2013 - 9:05am
tags:
Raptor Pharmaceuticals
J&J hunts for dengue fever drugs in tie-up with academia
Reuters
Thursday, August 29, 2013 - 9:05am
tags:
J&J, dengue, Janssen
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wednesday, August 28, 2013 - 4:53pm
tags:
monoclonal antibodies, Roche, Herceptin, Rituxan, Avastin, GSK, Amgen, Eli Lilly, Bristol-Myers Squibb, Seattle Genetics, Adcetris, Kadcyla, bapineuzumab, Elan, JNJ, Pfizer, necitumumab, AbbVie, Humira
A Closer Look at the Controversial Market Growth of ADHD Treatments
Motley Fool
Wednesday, August 28, 2013 - 4:49pm
tags:
ADHD, Shire, Adderall, Strattera, Eli Lilly, JNJ, Novartis, Concerta, Ritalin
Vertex Building A Fortress In Cystic Fibrosis
Investopedia
Wednesday, August 28, 2013 - 4:41pm
tags:
Vertex, cystic fibrosis, Gilead, GSK, Kalydeco, Bristol-Myers Squibb
Gilead's sofosbuvir cures some of the toughest hepatitis C cases
Fierce Biotech
Wednesday, August 28, 2013 - 12:38pm
tags:
hepatitis C, Gilead, sofosbuvir
Aceto: A Generic-Drug Growth Story
Seeking Alpha
Wednesday, August 28, 2013 - 12:37pm
tags:
Aceto, generics
Norway's Algeta says prostate cancer drug makes solid U.S. debut
Reuters
Wednesday, August 28, 2013 - 11:38am
tags:
Algeta, prostate cancer, Xofigo
Is the Biotech Bubble About to Burst?
Motley Fool
Wednesday, August 28, 2013 - 11:31am
tags:
biotech, Cytokinetics, Amgen, Celgene, Astex
Amgen CEO wins kudos for bagging Onyx at reasonable price
Fierce Pharma
Wednesday, August 28, 2013 - 10:47am
tags:
Amgen, ONYX Pharmaceuticals, M&A, Pharma CEOs, Robert Bradway
Arena Pharmaceuticals' candidate for pulmonary hypertension completes Phase 1b
Yahoo/Fly on the Wall
Wednesday, August 28, 2013 - 10:45am
tags:
PAH, pulmonary arterial hypertension, Arena Pharmaceuticals, APD811
Biotech: A Scattershot Of Stem Cell Plays Following Yesterday's Bloodbath
Seeking Alpha
Wednesday, August 28, 2013 - 9:52am
tags:
stem cells, StemCells, Pluristem, BioTime, BrainStorm Cell Therapeutics, Neuralstem
These biotech names are ripe for takeover: Cramer
CNBC
Wednesday, August 28, 2013 - 9:50am
tags:
M&A, Amgen, ONYX Pharmaceuticals, Medivation, Astellas, Seattle Genetics
InVivo shares plunge as co. says spinal cord study will take longer to enroll
Yahoo/AP
Wednesday, August 28, 2013 - 9:47am
tags:
InVivo, devices, spinal cord injury
Alimera, pSivida Eye Drug Warrants FDA Approval On Third Try
TheStreet.com
Wednesday, August 28, 2013 - 9:42am
tags:
Alimera, pSivida, FDA, drug approvals, Iluvien, diabetic macular edema
Astex Pharmaceuticals shares jump after drug developer announces preliminary study results
Yahoo/AP
Wednesday, August 28, 2013 - 9:10am
tags:
Astex, SGI-110, acute myeloid leukemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.